Nicholas Ceglia

9PUBLICATIONS
140CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityPredictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 22, 2026
Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones.

|Jan 07, 2026
IL10R Inhibition Induces Neutrophil Tumoricidal Activity.

Danny N Khalil, Ricardo Gomez, Amit Regev

|Jul 14, 2025
Complementary modes of resistance to EGFR TKI in lung adenocarcinoma through MAPK activation and cellular plasticity.

Matthew Zatzman, Alvaro Quintanal-Villalonga, Sohrab Salehi

|Jun 04, 2025
Disrupted priming within draining lymph nodes drives immune quiescence in gastric cancer.

Sohrab Salehi, Emily E Stroobant, Hannah Lees

|Jul 05, 2023
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer.

Steven B Maron, Walid Chatila, Henry Walch

|Jun 16, 2023
Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia.

Sanam Shahid, Nicholas Ceglia, Jean-Benoît Le Luduec

Pageof 2

Frequent Collaborators

4 joint publications

Sohrab Shah

4 joint publications

Taha Merghoub

3 joint publications

Isabell Schulze

3 joint publications

Sadna Budhu